Genomic technologies have pioneered the discovery of androgen-regulated genes (ARGs) and sought to determine how the aberrant expression of such genes contributes to the development and progression of localized PCa, mPCa, and CRPC4,27–29. The gene discussed is SERPINA2; the disease is posterior cortical atrophy.